Lehrstuhl für Geburtshilfe und Frauenheilkunde

Neoadjuvant trastuzumab emtansine and pertuzumab in human epidermal growth factor receptor 2–positive breast cancer: Three-year outcomes from the phase III KristinE study (2019) Hurvitz SA, Martin M, Jung KH, Huang CS, Harbeck N, Valero V, Stroyakovskiy D, et al. Journal article Ultrasound Fetal Weight Estimation in Diabetic Pregnancies (2019) Pretscher J, Kehl S, Stumpfe FM, Mayr A, Schmid M, Schild RL, Beckmann M, Faschingbauer F Journal article Ovarian Tissue Transplantation: Experience From Germany and Worldwide Efficacy (2019) Lotz L, Dittrich R, Hoffmann I, Beckmann M Journal article A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: Clinical results and biomarker analysis of GeparNuevo study (2019) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis (2019) Yarmolinsky J, Relton CL, Lophatananon A, Muir K, Menon U, Gentry-Maharaj A, Walther A, et al. Journal article SHEAR STRESS-DEPENDENT EXPRESSION OF GLYPICAN-4 AND HEPARAN SULFATE IN DIFFERENT PRIMARY HUMAN ENDOTHELIAL CELLS (2019) Hug K, Tauchi M, Raaz-Schrauder D, Stumpfe F, Achenbach S, Dietel-Schor B, Urschel K Conference contribution Comparison of preoperative and postoperative sexual function in patients with deeply infiltrating endometriosis with and without bowel resection (2019) Lermann J, Topal N, Renner SP, Beckmann M, Burghaus S, Adler W, Heindl F Journal article KATHERINE: Trastuzumab emtansine vs trastuzumab as adjuvant therapy in patients with HER2-positive early breast cancer (2019) Mamounas EP, Geyer CE, Huang CS, Mano MS, Loibl S, Untch M, Wolmark N, et al. Conference contribution Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study (2019) Wallwiener M, Nabieva N, Feisst M, Fehm T, De Waal J, Rezai M, Baier B, et al. Journal article Clarifications concerning the commentary "published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed" (2019) Koch M, Lermann J, Van De Roemer N, Renner SK, Burghaus S, Hackl J, Dittrich R, et al. Journal article